Sun Mi Kim

Seoul National University Bundang Hospital — South Korea

Medicine · Health Sciences

38h-index4.2kcitations242works3.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Lesions and Carcinomas(53), Breast Cancer Treatment Studies(43), AI in cancer detection(34), Radiomics and Machine Learning in Medical Imaging(26), Catalytic Processes in Materials Science(23)

Publications242 total

Angiovolume and Peak Enhancement on Preoperative CAD-Derived MRI as Prognostic Factors in Primary Operable Triple-Negative Breast Cancer
Tomography·2025Open Access
The Effect of Carbon-Neutral Activities Using a Maker Mindset on Ecological Sensitivity and Creative Problem-Solving Skills in Young Children
Korean Association For Learner-Centered Curriculum And Instruction·2025
Overcoming melanin interference in melanocyte photodynamic therapy with a pyrene-derived two-photon photosensitizer
Chemical Engineering Journal·2024· 8 cited
Concordance of HER2 status between core needle biopsy and surgical resection specimens of breast cancer: an analysis focusing on the HER2-low status
Breast Cancer·2024· 11 citedOpen Access
The Effect of Incosistent Parenting Attitudes on Adolescents’ Social Withdrawal and Life Satisfaction: Verification of Longitudinal Mediating Effect Using the Latent Growth Model
Korean Journal of Youth Studies·2024· 1 cited
Automated Versus Handheld Breast Ultrasound for Evaluating Axillary Lymph Nodes in Patients With Breast Cancer
Korean Journal of Radiology·2024· 3 citedOpen Access
Background Breast Parenchymal Signal During Menstrual Cycle on Diffusion-Weighted MRI: A Prospective Study in Healthy Premenopausal Women
Korean Journal of Radiology·2024· 2 citedOpen Access
Exploration of Core Competencies from Delphi Survey and Design of Their Measurement Tools and Teaching & Learning Programs for Environmental Education in Elementary Schools
Institute of Brain-based Education Korea National University of Education·2023
A Delphi Analysis on E-Commerce Services in the Era of Mobile Platforms : Focusing on TV Home-Shopping Network’s Strategic Use of Online Live-Streaming Commerce Services
Journal of Speech Media & Communication Research·2023
Data from Glycolysis Inhibition Sensitizes Non–Small Cell Lung Cancer with T790M Mutation to Irreversible EGFR Inhibitors via Translational Suppression of Mcl-1 by AMPK Activation
2023Open Access
Supplementary Figure 1 from Glycolysis Inhibition Sensitizes Non–Small Cell Lung Cancer with T790M Mutation to Irreversible EGFR Inhibitors via Translational Suppression of Mcl-1 by AMPK Activation
2023Open Access
Supplementary Figure Legends and Methods from Glycolysis Inhibition Sensitizes Non–Small Cell Lung Cancer with T790M Mutation to Irreversible EGFR Inhibitors via Translational Suppression of Mcl-1 by AMPK Activation
2023Open Access
Supplementary Figure 7 from Activation of IL-6R/JAK1/STAT3 Signaling Induces <i>De Novo</i> Resistance to Irreversible EGFR Inhibitors in Non–Small Cell Lung Cancer with T790M Resistance Mutation
2023Open Access
Supplementary Figure 5 from Glycolysis Inhibition Sensitizes Non–Small Cell Lung Cancer with T790M Mutation to Irreversible EGFR Inhibitors via Translational Suppression of Mcl-1 by AMPK Activation
2023Open Access
Supplementary Figure 5 from Activation of IL-6R/JAK1/STAT3 Signaling Induces <i>De Novo</i> Resistance to Irreversible EGFR Inhibitors in Non–Small Cell Lung Cancer with T790M Resistance Mutation
2023Open Access
Supplementary Figure 6 from Activation of IL-6R/JAK1/STAT3 Signaling Induces <i>De Novo</i> Resistance to Irreversible EGFR Inhibitors in Non–Small Cell Lung Cancer with T790M Resistance Mutation
2023Open Access
Supplementary Figure 4 from Activation of IL-6R/JAK1/STAT3 Signaling Induces <i>De Novo</i> Resistance to Irreversible EGFR Inhibitors in Non–Small Cell Lung Cancer with T790M Resistance Mutation
2023Open Access
Supplementary Figure 4 from Activation of IL-6R/JAK1/STAT3 Signaling Induces <i>De Novo</i> Resistance to Irreversible EGFR Inhibitors in Non–Small Cell Lung Cancer with T790M Resistance Mutation
2023Open Access
Supplementary Figure 7 from Activation of IL-6R/JAK1/STAT3 Signaling Induces <i>De Novo</i> Resistance to Irreversible EGFR Inhibitors in Non–Small Cell Lung Cancer with T790M Resistance Mutation
2023Open Access
Data from Activation of IL-6R/JAK1/STAT3 Signaling Induces <i>De Novo</i> Resistance to Irreversible EGFR Inhibitors in Non–Small Cell Lung Cancer with T790M Resistance Mutation
2023Open Access
page 1 of 13Next →

Frequent Co-authors

Nariya Cho(12), Woo Kyung Moon(12), Bo La Yun(12), Mijung Jang(12), Jeong Young Park(11), Joo Hee(8), Eunyoung Kang(7), So Yeon Park(7), Hak Hee Kim(4), Bohyoung Kim(4), Sung‐Won Kim(4), Boo‐Kyung Han(3), Eun Sook Ko(3), Hee Jung Shin(3), Gyungyub Gong(3), Jeong Seon Park(3), Sang Hoon Kim(3), Eun‐Kyu Kim(3), Jung Min Chang(3), Wonshik Han(2)